NEW! DVDs for PharmedOut's 2011 conference are now available. Quantities are limited, so order yours today!
Home
About Us
Publications
PhO in the Media
Our Conferences
Resources
Pharma-Free CME
Teaching Tools
News Archive
Drug Industry
Contact Us
How You Can Help
NEWS FEED
Drug Company Funding Disclosures
Cephalon: payments to individuals
Minnesota Board of Pharmacy Payments to Practitioners Documents
Pharmaceutical Marketing Disclosures: Report of Vermont Attorney General William H. Sorrell on Payments to Physicians (read more)
Blogs (link to list)
Cafepharma: Drug Rep Message Board
Pharmaceutical Research and Manufacturers of America (PhRMA): Trade Group
Major Global Companies
Blogs (back to menu)
Ratings of industry bias are from a survey by John Mack in Pharma Marketing News in March 2007.
Green = "Supportive" of industry
Blue = Balanced (from "Critical but Helpful" to "Supportive and helpful") (back to Resources by Topic or Resources by Type)
Our Videos
Pharma Insider II
Opposition research
(read transcript)
Pharma Insider I
Off-label promotion under the radar
(read transcript)
The Art of Medical Writing
Pharma's anonymous writers
Drug Reps Talk Shop II
Drug reps continue their chat
Drug Reps Talk Shop I Selling drugs to docs
Director of PharmedOut Explains the Project
Zyprexa Drug Rep Tells All Shahram Ahari describes how he sold the drug
News
Drug Firms Turn to Private Docs to Promote Products
University ethics policies tightened Milwaukee Journal Sentinel
J&J Pushed Risperdal After Warning, Files Show
FDA ignored; CME supported off-label uses Bloomberg
NIH Should Disclose Financial Conflicts
Public database requested Pharmalot
Diabetes Heart Treatments May Cause Harm
Normalizing BP and postprandial hyperglycemia don't help NYT
Grassley Tells PBMs To Disclose Ties To Pharma
Drugmakers may provide financial benefits Pharmalot
Analysis Finds Vioxx's Heart Attack Risk in 2001
35% increase in CV events WSJ
States, Consumer Advocates Challenge Rx Data Mining
FDA has been silent Chicago Tribune
Researcher Seeks New Treatments in Old Drugs
Bioinformatics promising Houston Chronicle
Some Doctors Say No More Free Lunches
“Goodies” are a conflict of interest Rapid City Journal
Study Raises Questions About Cholesterol Drug’s Benefit
Niacin bests Zetia NYT
Drug Makers Raise Prices in Face of Health Care Reform
Wholesale prices up 9% NYT
Commentary
Mammography and the Corporate Breast
Conflicts of USPSTF critics not mentioned Bioethics Forum
Click HERE to read the entire news archives
Department of Pharmacology * Med-Dent Bldg, Rm SE402 * Washington, DC 20057-1460